CEBP Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Therapeutics and Targets

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 133 total displayed.

Most recent content

Cancer Res.
Reviews
iASPP Inhibition: Increased Options in Targeting the p53 Family for Cancer Therapy
Helen S. Bell and Kevin M. Ryan
Cancer Res. 2008; 68: 4959-4962. [Abstract] [Full text] [PDF]  

Past content

Mol. Cancer Res.
Subject Reviews
Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective
Chih-Pin Chuu, Rou-Yu Chen, John L. Barkinge, Mark F. Ciaccio, and Richard B. Jones
Mol. Cancer Res. 2008; 6: 885-891. [Abstract] [Full text] [PDF]  

Mol. Cancer Res.
Subject Reviews
Zinc {alpha}2-Glycoprotein: A Multidisciplinary Protein
Md. Imtaiyaz Hassan, Abdul Waheed, Savita Yadav, Tej P. Singh, and Faizan Ahmad
Mol. Cancer Res. 2008; 6: 892-906. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Review
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies
Jorge A. Garcia and David Danielpour
Mol. Cancer Ther. 2008; 7: 1347-1354. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Unraveling the Mystery of Erythropoietin-Stimulating Agents in Cancer Promotion
Kelly A. May and Fadlo R. Khuri
Cancer Res. 2008; 68: 4013-4017. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies
Lionel Apetoh, Antoine Tesniere, François Ghiringhelli, Guido Kroemer, and Laurence Zitvogel
Cancer Res. 2008; 68: 4026-4030. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Review
Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors
Hong Su, Lucia Altucci, and Qidong You
Mol. Cancer Ther. 2008; 7: 1007-1012. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Oncogene Addiction
I. Bernard Weinstein, Andrew Joe, and Dean Felsher
Cancer Res. 2008; 68: 3077-3080. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Oncogene Addiction versus Oncogene Amnesia: Perhaps More than Just a Bad Habit?
Dean W. Felsher, I. Bernard Weinstein, and Andrew Joe
Cancer Res. 2008; 68: 3081-3086. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Role of the Aggresome Pathway in Cancer: Targeting Histone Deacetylase 6–Dependent Protein Degradation
Agustin Rodriguez-Gonzalez, Tara Lin, Alan K. Ikeda, Tiffany Simms-Waldrip, Cecilia Fu, and Kathleen M. Sakamoto
Cancer Res. 2008; 68: 2557-2560. [Abstract] [Full text] [PDF]  

[Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

* Collected Resources Home


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.